APOA1 and metabolic syndrome: Notably, certain metabolites such as glycoprotein acetyls, ApoB/ApoA1 ratio, and lactate emerge as promising biomarkers for insulin resistance and metabolic syndrome, suggesting their potential utility in clinical settings.